Skip Ribbon Commands
Skip to main content
Sign In

22896 Myocarditis-Perocarditis Antibody Panel (FMYPP)

Myocarditis-Perocarditis Antibody Panel (FMYPP)
Test Code: MYPERSO
Synonyms/Keywords
Myocarditis/Pericarditis Panel
Specimen Requirements
Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
Serum​ ​Red Top Tube (RTT) ​Serum Separator Tube (SST) ​3 mL ​2 mL
Specimen Stability Information
Specimen Type Temperature Time
​Serum ​ ​ ​Refrigerated (preferred) ​14 days
​Frozen ​30 days
​Ambient ​7 days
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation

​Mayo Clinic Laboratories who forwards to Quest Diagnostics Infectious Disease

Monday through Saturday ​2-9 days
Complement Fixation (CF)/Immunoflourescence Assay (IFA)
Reference Lab
Test Information

​Panel includes Coxsackie B (1,2,3,4,5 & 6), Echovirus, Influenza A and B virus antibody tests, and Chlamydophila Pneumoniae Antodies (IgG, IgA, IgM).

Mayo Clinic Laboratories forwards this test to Quest Diagnostics Infectious Disease

Reference Range Information

COXSACKIE B(1-6) ANTIBODIES, SERUM

    REFERENCE RANGE: <1:8

    INTERPRETIVE CRITERIA:

            <1:8 Antibody Not Detected

            > or = 1:8 Antibody Detected 

Single titers of > or = 1:32 are indicative of recent infection. Titers of 1:8 or 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is considerable crossreactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype.

This test was developed and its performance characteristics have been determined by Quest Diagnostics Infectious Disease. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

 

ECHOVIRUS ANTIBODIES, SERUM

    REFERENCE RANGE: <1:8

    INTERPRETIVE CRITERIA:

            <1:8 Antibody Not Detected

            > or = 1:8 Antibody Detected

Single titers > or = 1:32 are indicative of recent infection. Titers of 1:8 and 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is considerable crossreactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype.

This test was developed and its performance characteristics have been determined by Quest Diagnostics Infectious Disease. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

 

INFLUENZA TYPES A AND B ANTIBODIES, SERUM

    REFERENCE RANGE: <1:8

    INTERPRETIVE CRITERIA:

            <1:8 Antibody Not Detected

            > or = 1:8 Antibody Detected

Single titers of > or = 1:64 are indicative of recent infection. Titers of 1:8 to 1:32 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis.

This test was developed and its performance characteristics have been determined by Quest Diagnostics Infectious Disease. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

 

CHLAMYDOPHILA PNEUMONIAE ANTIBODIES (IgG, IgA, IgM)

    REFERENCE RANGE:    IgG <1:64

                                          IgA <1:16

                                          IgM <1:10

The immunofluorescent detection of specific antibodies to Chlamydophila pneumoniae may be complicated by cross-reactive antibodies, non-specific antibody stimulation, or past exposure to similar organisms such as C. psittaci and Chlamydia trachomatis. IgM titers of 1:10 or greater usually indicate recent infection, and any IgG titer may indicate past exposure. IgA is typically present at low titers during primary infection, but may be elevated in recurrent exposures or in chronic infection.

Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
86658​ ​11 ​Enterovirus antibody
​86710 ​2 ​Influenza antibody
​86331 ​2 ​Gel diffusion
​86632 ​Chlamydia IgM
Synonyms/Keywords
Myocarditis/Pericarditis Panel
Ordering Applications
Ordering Application Description
​Centricity ​Myocard-Pericard Pan
​Cerner ​Mycocarditis-Pericarditis Panel (91332)
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
Serum​ ​Red Top Tube (RTT) ​Serum Separator Tube (SST) ​3 mL ​2 mL
Specimen Stability Information
Specimen Type Temperature Time
​Serum ​ ​ ​Refrigerated (preferred) ​14 days
​Frozen ​30 days
​Ambient ​7 days
Reference Range Information

COXSACKIE B(1-6) ANTIBODIES, SERUM

    REFERENCE RANGE: <1:8

    INTERPRETIVE CRITERIA:

            <1:8 Antibody Not Detected

            > or = 1:8 Antibody Detected 

Single titers of > or = 1:32 are indicative of recent infection. Titers of 1:8 or 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is considerable crossreactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype.

This test was developed and its performance characteristics have been determined by Quest Diagnostics Infectious Disease. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

 

ECHOVIRUS ANTIBODIES, SERUM

    REFERENCE RANGE: <1:8

    INTERPRETIVE CRITERIA:

            <1:8 Antibody Not Detected

            > or = 1:8 Antibody Detected

Single titers > or = 1:32 are indicative of recent infection. Titers of 1:8 and 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is considerable crossreactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype.

This test was developed and its performance characteristics have been determined by Quest Diagnostics Infectious Disease. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

 

INFLUENZA TYPES A AND B ANTIBODIES, SERUM

    REFERENCE RANGE: <1:8

    INTERPRETIVE CRITERIA:

            <1:8 Antibody Not Detected

            > or = 1:8 Antibody Detected

Single titers of > or = 1:64 are indicative of recent infection. Titers of 1:8 to 1:32 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis.

This test was developed and its performance characteristics have been determined by Quest Diagnostics Infectious Disease. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

 

CHLAMYDOPHILA PNEUMONIAE ANTIBODIES (IgG, IgA, IgM)

    REFERENCE RANGE:    IgG <1:64

                                          IgA <1:16

                                          IgM <1:10

The immunofluorescent detection of specific antibodies to Chlamydophila pneumoniae may be complicated by cross-reactive antibodies, non-specific antibody stimulation, or past exposure to similar organisms such as C. psittaci and Chlamydia trachomatis. IgM titers of 1:10 or greater usually indicate recent infection, and any IgG titer may indicate past exposure. IgA is typically present at low titers during primary infection, but may be elevated in recurrent exposures or in chronic infection.

For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation

​Mayo Clinic Laboratories who forwards to Quest Diagnostics Infectious Disease

Monday through Saturday ​2-9 days
Complement Fixation (CF)/Immunoflourescence Assay (IFA)
Reference Lab
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
86658​ ​11 ​Enterovirus antibody
​86710 ​2 ​Influenza antibody
​86331 ​2 ​Gel diffusion
​86632 ​Chlamydia IgM
For most current information refer to the Marshfield Laboratory online reference manual.